WuXi Biologics and Aravive join forces on high-affinity bispecific antibodies

The collaboration will target cancer and fibrosis and use the WuXiBody Platform

picture of

Breaking News

VistaGen and Nuformix agree to develop cocrystalline forms of AV-101

The drug for treatment of multiple CNS conditions will be reformed into a novel patentable form to potentially improve ...

Beximco Pharma introduces first generic remdesivir for COVID-19

Beximco Pharma is donating remdesivir (Bemsivir) to the Bangladesh Government for supply only to Government hospitals

BioMed X launches rapid antiviral response platform

BioMed X is striving to develop an arsenal of ultrafast new antiviral drug discovery, development and mass-m ...

Nitrosamines: Information for Marketing Authorisation Holders

Nitrosamine impurities have been in the regulatory spotlight since they were discovered in several blood pressure ...

HKBU scientists develop technique to eliminate drug chirality side effects

Scientists from Hong Kong Baptist University have used a nanostructure fabrication device to manipulate the chirality ...

Vibalogics to support Johnson & Johnson vaccine effort

The global CDMO that specialises in the production of virotherapy products has announced that it will manufacture ...

How to comply with FDA-imposed nitrosamine impurity testing

The detection of nitrosamine impurities in commercially available drugs has recently prompted the US FDA to issue ...

galenIQ makes sugar-free medicated high-boiled lozenges with a long shelf-life

BENEO’s sweet-tasting excipient galenIQ 900 provides both manufacturers and consumers alike with technological and ...

Colorcon launches SoteriaRx on-dose authentication technology platform

New platform of innovative on-dose technologies and detection services for the authentication of medications will help ...

The Lonza powder-in-capsule microdosing approach

Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...

Excipient innovation for enhanced patient compliance: part II

Formulation can be challenging, particularly when working with excipients such as sugar alcohols. However, a new line ...

UK medical cannabis: quality under scrutiny

Andrew James, Marketing Director of Ellutia, explains how chromatography can uncover the potency of a batch of cannabis ...

Respiratory drug specialist opens critical care division in wake of pandemic

Senzer Pharmaceuticals has launched a Critical Care Division that will use its expertise in respiratory pharmaceuticals ...

Cipla signs COVID-19 licensing agreement with Gilead Sciences

Indian Cipla will be permitted to manufacture US-based Gilead’s API and finished product of Remdesivir and market it ...